These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35373634)

  • 1. Developing Economic Models for Assessing the Cost-Effectiveness of Multiple Diagnostic Tests: Methods and Applications.
    Xie X; Tiggelaar S; Guo J; Wang M; Vandersluis S; Ungar WJ
    Med Decis Making; 2022 Oct; 42(7):861-871. PubMed ID: 35373634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating sensitivity and specificity of diagnostic tests using latent class models that account for conditional dependence between tests: a simulation study.
    Keddie SH; Baerenbold O; Keogh RH; Bradley J
    BMC Med Res Methodol; 2023 Mar; 23(1):58. PubMed ID: 36894883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments.
    Shinkins B; Yang Y; Abel L; Fanshawe TR
    BMC Med Res Methodol; 2017 Apr; 17(1):56. PubMed ID: 28410588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
    Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
    Heather EM; Payne K; Harrison M; Symmons DP
    Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model.
    Whiting P; Westwood M; Bojke L; Palmer S; Richardson G; Cooper J; Watt I; Glanville J; Sculpher M; Kleijnen J
    Health Technol Assess; 2006 Oct; 10(36):iii-iv, xi-xiii, 1-154. PubMed ID: 17014747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.
    de Verteuil R; Imamura M; Zhu S; Glazener C; Fraser C; Munro N; Hutchison J; Grant A; Coyle D; Coyle K; Vale L
    Health Technol Assess; 2008 Jun; 12(26):iii-iv, ix-223. PubMed ID: 18513467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis.
    Freeman K; Mistry H; Tsertsvadze A; Royle P; McCarthy N; Taylor-Phillips S; Manuel R; Mason J
    Health Technol Assess; 2017 Apr; 21(23):1-188. PubMed ID: 28619124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
    Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
    Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
    Seo MK; Cairns J
    BMC Cancer; 2021 Sep; 21(1):980. PubMed ID: 34470603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
    Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
    Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the accuracy and economic value of a new test in the absence of a perfect reference test.
    Xie X; Sinclair A; Dendukuri N
    Res Synth Methods; 2017 Sep; 8(3):321-332. PubMed ID: 28544646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
    Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
    Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.